Search results for "censoring"

showing 9 items of 9 documents

cglasso: An R Package for Conditional Graphical Lasso Inference with Censored and Missing Values

2023

Sparse graphical models have revolutionized multivariate inference. With the advent of high-dimensional multivariate data in many applied fields, these methods are able to detect a much lower-dimensional structure, often represented via a sparse conditional independence graph. There have been numerous extensions of such methods in the past decade. Many practical applications have additional covariates or suffer from missing or censored data. Despite the development of these extensions of sparse inference methods for graphical models, there have been so far no implementations for, e.g., conditional graphical models. Here we present the general-purpose package cglasso for estimating sparse co…

Statistics and Probabilityconditional Gaussian graphical modelscglasso conditional Gaussian graphical models glasso high-dimensionality sparsity censoring missing dataglassosparsityhigh-dimensionalityconditional Gaussian graphical models glasso high-dimensionality sparsity censoring missing datacglassomissing datacensoringStatistics Probability and UncertaintySettore SECS-S/01 - StatisticaSoftware
researchProduct

Estimation of Values below the Limit of Detection of a Contemporary Sensitive Troponin I Assay Improves Diagnosis of Acute Myocardial Infarction

2015

Abstract BACKGROUND The limit of detection (LoD) is the minimal amount of a substance that can be consistently detected. In the diagnosis of acute myocardial infarction (AMI) many patients present with troponin concentrations below the LoD of contemporary sensitive cardiac troponin I (cs-cTnI) assays. These censored values below the LoD influence the diagnostic performance of these assays compared to highly sensitive cTnI (hs-cTnI) assays. Therefore we assessed the impact of a new approach for interpolation of the left-censored data of a cs-cTnI assay in the evaluation of patients with suspected AMI. METHODS Our posthoc analysis used a real world cohort of 1818 patients with suspected MI. D…

Malemedicine.medical_specialtyClinical BiochemistryMyocardial Infarctionmacromolecular substancesCohort StudiesLimit of DetectionInternal medicineTroponin ImedicineHumanscardiovascular diseasesMyocardial infarctionAgedAged 80 and overDetection limitbiologybusiness.industryTroponin IBiochemistry (medical)Area under the curveMiddle AgedPrognosismedicine.diseaseTroponinCensoring (statistics)SurgeryROC CurveArea Under CurveAcute DiseaseCohortcardiovascular systemCardiologybiology.proteinRegression AnalysisFemaleMyocardial infarction diagnosisbusinessClinical Chemistry
researchProduct

L1-Penalized Censored Gaussian Graphical Model

2018

Graphical lasso is one of the most used estimators for inferring genetic networks. Despite its diffusion, there are several fields in applied research where the limits of detection of modern measurement technologies make the use of this estimator theoretically unfounded, even when the assumption of a multivariate Gaussian distribution is satisfied. Typical examples are data generated by polymerase chain reactions and flow cytometer. The combination of censoring and high-dimensionality make inference of the underlying genetic networks from these data very challenging. In this article, we propose an $\ell_1$-penalized Gaussian graphical model for censored data and derive two EM-like algorithm…

0301 basic medicineStatistics and ProbabilityFOS: Computer and information sciencesgraphical lassoComputer scienceGaussianNormal DistributionInferenceMultivariate normal distribution01 natural sciencesMethodology (stat.ME)010104 statistics & probability03 medical and health sciencessymbols.namesakeGraphical LassoExpectation–maximization algorithmHumansComputer SimulationGene Regulatory NetworksGraphical model0101 mathematicsStatistics - MethodologyEstimation theoryReverse Transcriptase Polymerase Chain ReactionEstimatorexpectation-maximization algorithmGeneral MedicineCensoring (statistics)High-dimensional datahigh-dimensional dataGaussian graphical model030104 developmental biologysymbolscensored dataCensored dataExpectation-Maximization algorithmStatistics Probability and UncertaintySettore SECS-S/01 - StatisticaAlgorithmAlgorithms
researchProduct

Protest beliefs in contingent valuation: Explaining their motivation

2006

Abstract The definition and treatment of protest responses in contingent valuation (CV) can have a significant influence on the estimated values of the good in question if these responses are censored. In order to understand how protest responses are motivated, in a CV about forest biodiversity in Germany we used an item battery to identify respondents' protest beliefs. The items were measured for all respondents, irrespective of their willingness to pay (WTP) in principle. Then, a scale based on these beliefs is taken as a dependent variable of regression analyses. In addition to environmental concern we used norms, the warm glow of giving and dilemma concern as further explanatory variabl…

Economics and EconometricsContingent valuationActuarial scienceVariablesmedia_common.quotation_subjectDilemmaWillingness to payOrder (exchange)Censoring (clinical trials)Scale (social sciences)EconomicsSocial psychologyGeneral Environmental ScienceForest biodiversitymedia_commonEcological Economics
researchProduct

Sample size planning for survival prediction with focus on high-dimensional data

2011

Sample size planning should reflect the primary objective of a trial. If the primary objective is prediction, the sample size determination should focus on prediction accuracy instead of power. We present formulas for the determination of training set sample size for survival prediction. Sample size is chosen to control the difference between optimal and expected prediction error. Prediction is carried out by Cox proportional hazards models. The general approach considers censoring as well as low-dimensional and high-dimensional explanatory variables. For dimension reduction in the high-dimensional setting, a variable selection step is inserted. If not all informative variables are included…

Statistics and ProbabilityClustering high-dimensional dataClinical Trials as TopicLung NeoplasmsModels StatisticalKaplan-Meier EstimateEpidemiologyProportional hazards modelDimensionality reductionGene ExpressionFeature selectionKaplan-Meier EstimateBiostatisticsPrognosisBrier scoreSample size determinationCarcinoma Non-Small-Cell LungSample SizeCensoring (clinical trials)StatisticsHumansProportional Hazards ModelsMathematicsStatistics in Medicine
researchProduct

The conditional censored graphical lasso estimator

2020

© 2020, Springer Science+Business Media, LLC, part of Springer Nature. In many applied fields, such as genomics, different types of data are collected on the same system, and it is not uncommon that some of these datasets are subject to censoring as a result of the measurement technologies used, such as data generated by polymerase chain reactions and flow cytometer. When the overall objective is that of network inference, at possibly different levels of a system, information coming from different sources and/or different steps of the analysis can be integrated into one model with the use of conditional graphical models. In this paper, we develop a doubly penalized inferential procedure for…

Statistics and ProbabilityFOS: Computer and information sciencesComputer scienceGaussianInferenceData typeTheoretical Computer Sciencehigh-dimensional settingDatabase normalizationMethodology (stat.ME)symbols.namesakeLasso (statistics)Graphical modelConditional Gaussian graphical modelcensored graphical lassoStatistics - MethodologyHigh-dimensional settingconditional Gaussian graphical modelssparsityEstimatorCensoring (statistics)Censored graphical lassoComputational Theory and MathematicssymbolsCensored dataStatistics Probability and UncertaintySettore SECS-S/01 - StatisticaSparsityAlgorithm
researchProduct

A Prognostic Model for Estimating the Time to Virologic Failure in HIV-1 Infected Patients Undergoing a New Combination Antiretroviral Therapy Regimen

2011

Abstract Background HIV-1 genotypic susceptibility scores (GSSs) were proven to be significant prognostic factors of fixed time-point virologic outcomes after combination antiretroviral therapy (cART) switch/initiation. However, their relative-hazard for the time to virologic failure has not been thoroughly investigated, and an expert system that is able to predict how long a new cART regimen will remain effective has never been designed. Methods We analyzed patients of the Italian ARCA cohort starting a new cART from 1999 onwards either after virologic failure or as treatment-naïve. The time to virologic failure was the endpoint, from the 90th day after treatment start, defined as the firs…

OncologyMaleAdult; Anti-HIV Agents; Cohort Studies; Drug Therapy Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Proportional Hazards Models; Treatment Failure; Viral LoadHIV InfectionsCohort Studies0302 clinical medicineANTIRETROVIRAL THERAPYMedicineHIV Infection030212 general & internal medicineTreatment Failure0303 health sciencesHealth PolicyMiddle AgedViral Load3. Good healthComputer Science ApplicationsCensoring (clinical trials)CohortCombinationlcsh:R858-859.7Drug Therapy CombinationFemaleViral loadHumanResearch ArticleCartAdultmedicine.medical_specialtyAnti-HIV AgentsHIV-1; antiretroviral therapyHealth InformaticsSettore MED/17 - MALATTIE INFETTIVElcsh:Computer applications to medicine. Medical informatics03 medical and health sciencesDrug TherapyInternal medicineHumansSurvival analysisProportional Hazards Models030306 microbiologybusiness.industryProportional hazards modelAdult; Anti-HIV Agents; Cohort Studies; Drug Therapy Combination; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Proportional Hazards Models; Treatment Failure; Viral Load; Health Informatics; Health PolicyANTIRETROVIRAL DRUGSAnti-HIV AgentHIVGENOTYPESDiscontinuationRegimenImmunologyProportional Hazards ModelHIV-1Cohort StudiebusinessBMC Medical Informatics and Decision Making
researchProduct

Memory‐type control charts for censored reliability data

2023

Control charts are commonly used to monitor a process to detect undesirable changes. The main goal of this work is to propose exponentially weighted moving average (EWMA) and cumulative sum (CUSUM) control charts to track a process by utilizing type-I censored generalized exponential (GE) distributed data. In particular, the censored data are replaced with the conditional expected value (CEV). A comparison between CUSUM and CUSUM ignoring unobserved covariates (CUSUM-IUC) charts is also a part of this study. The GE distribution is considered due to its application in reliability analysis. The performance of the charts is evaluated by using the average run length along with the standard devi…

exponentially weighted moving averageAverage run lengthSettore SECS-S/02 - Statistica Per La Ricerca Sperimentale E Tecnologicastandard deviation of run lengthcumulative sumManagement Science and Operations ResearchType-I censoringSafety Risk Reliability and QualityQuality and Reliability Engineering International
researchProduct

Power of the Wilcoxon–Mann–Whitney test for non‐inferiority in the presence of death‐censored observations

2017

In clinical trials with patients in a critical state, death may preclude measurement of a quantitative endpoint of interest, and even early measurements, for example for intention-to-treat analysis, may not be available. For example, a non-negligible proportion of patients with acute pulmonary embolism will die before 30 day measurements on the efficacy of thrombolysis can be obtained. As excluding such patients may introduce bias, alternative analyses, and corresponding means for sample size calculation are needed. We specifically consider power analysis in a randomized clinical trial setting in which the goal is to demonstrate noninferiority of a new treatment as compared to a reference t…

Statistics and ProbabilityClinical Trials as TopicBiometryEndpoint Determinationbusiness.industryNonparametric statisticsGeneral Medicinemedicine.diseaseOutcome (probability)Pulmonary embolismlaw.inventionDeathClinical trialRandomized controlled trialSample size determinationlawCensoring (clinical trials)StatisticsMann–Whitney U testHumansMedicineStatistics Probability and UncertaintyPulmonary EmbolismbusinessBiometrical Journal
researchProduct